Metabolic Effect of 3,3\u27,5\u27-Triiodothyronine in Cultured Growth Hormone-Producing Rat Pituitary Tumor Cells. Evidence for a Unique Mechanism of Thyroid Hormone Action. by St Germain, D L
Dartmouth College
Dartmouth Digital Commons
Open Dartmouth: Faculty Open Access Articles
8-1-1985
Metabolic Effect of 3,3',5'-Triiodothyronine in
Cultured Growth Hormone-Producing Rat
Pituitary Tumor Cells. Evidence for a Unique
Mechanism of Thyroid Hormone Action.
D L. St Germain
Dartmouth College
Follow this and additional works at: https://digitalcommons.dartmouth.edu/facoa
Part of the Medicine and Health Sciences Commons
This Article is brought to you for free and open access by Dartmouth Digital Commons. It has been accepted for inclusion in Open Dartmouth: Faculty
Open Access Articles by an authorized administrator of Dartmouth Digital Commons. For more information, please contact
dartmouthdigitalcommons@groups.dartmouth.edu.
Recommended Citation
St Germain, D L., "Metabolic Effect of 3,3',5'-Triiodothyronine in Cultured Growth Hormone-Producing Rat Pituitary Tumor Cells.
Evidence for a Unique Mechanism of Thyroid Hormone Action." (1985). Open Dartmouth: Faculty Open Access Articles. 3745.
https://digitalcommons.dartmouth.edu/facoa/3745
Rapid Publication
Metabolic Effect of 3,3',5'-Triiodothyronine in Cultured Growth
Hormone-producing Rat Pituitary Tumor Cells
Evidence for a Unique Mechanism of Thyroid Hormone Action
Donald L. St. Germain
Departments ofMedicine and Physiology, Dartmouth Medical School, Hanover, New Hampshire 03756
Abstract
Physiologic levels of 3,3',5'-triiodothyronine (rT3) are generally
believed to have minimal metabolic effects in the pituitary
gland and other tissues. In the present studies, the regulatory
role of rT3 and other thyroid hormones on iodothyronine 5'-
deiodinase (15D) activity was studied in a growth hormone-
producing rat pituitary tumor cell line (GH3 cells). O5D activity
was thiol-dependent and displayed nonlinear reaction kinetics
suggesting the presence of two enzymatic processes, one having
a low Michaelis constant (K. for thyroxine IT41 of 2 nM) and
a second with a high K. value (0.9 MM). Growth of cells in
hormone-depleted medium resulted in a two- to 3.5-fold increase
in low K. 151D activity (P < 0.001). The addition of thyroid
hormones to the culture medium resulted in a rapid, dose-
dependent inhibition of low K. 151) activity with the following
order of analogue potency: rT3 2 T4> 3,5,3'-triiodothyronine
(T3). Using serum-free culture conditions rT3 was - 50 times
more active than Tj. These inhibitory effects were noted within
15 min of hormone addition and could not be attributed to
substrate competition with T4. These findings suggest that the
control of T4 to T3 conversion by thyroid hormones in the
anterior pituitary gland is mediated by a unique cellular
mechanism that is independent of the nuclear T3 receptor, and
under some circumstances, rT3 may play a regulatory role in
controlling this enzymatic process.
Introduction
The metabolic actions of thyroid hormones appear to be
mediated primarily through the interaction of 3,5,3'-triiodo-
thyronine (T3) with specific nuclear receptors (1). In the
various growth hormone-producing rat pituitary tumor cell
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1. Abbreviations used in this paper: DTT, dithiothreitol; FCS, fetal calf
serum; GH cells, growth hormone-producing cell lines; HS, horse
serum; 15'D, iodothyronine 5'-deiodinase; K., Michaelis constant; rT3,
3,3',5'-triiodothyronine; T3, 3,5,3'-triiodothyronine; T4, thyroxine.
lines (GH cells) for example, T3 is the most potent thyroid
hormone analogue in stimulating glucose consumption (2),
growth hormone production (3), and amino acid transport (4),
and these effects correlate well with the proportion of nuclear
binding sites occupied by T3. Although 3,3',5Y-triiodothyronine
(rT3) also has agonist activity in GH cells, 1,000-fold greater
concentrations are required, presumably due to the nuclear
receptor having a significantly lower affinity for rT3 (5). In
other systems, the metabolic effects ofrT3 also appear to be mini-
mal (5).
In the present studies, we used the GH3 cell line to
investigate the regulatory effects of thyroid hormones on a low
Michaelis constant (Ki) iodothyronine 5'-deiodinase (I51D)
process (type II). Our finding that rT3 is a potent and rapid
inhibitor of this enzymatic process suggests that thyroid hor-
mone control of T3 formation in anterior pituitary tissue is
mediated through a unique cellular mechanism that is inde-
pendent of the nuclear T3 receptor.
Methods
GH3 cells were obtained from the American Type Culture Collection
(Rockville, MD) and were routinely grown in 75-cm2 plastic flasks and
100-mm plastic culture dishes using Ham's F-10 culture medium
supplemented with 2.5% fetal calf serum (FCS), 15% horse serum
(HS), and gentamycin (50 usg/ml) in a humidified atmosphere of 5%
C02/95% air. Medium was routinely changed twice weekly. In some
experiments cells were grown to near confluence in standard medium
and then transferred and maintained for 4 d in serum-free Ham's F-
10 or in Ham's F-10 supplemented with FCS (10%) that previously
had been treated with either charcoal (6) or an ion exchange resin (7).
According to the manufacturer's (HyClone Laboratories, Logan, UT)
specifications, the T4 and T3 levels were 12.7 ;g/dl and 118 ng/dl,
respectively, in the FCS and 2.9 gg/dl and 47 ng/dl, respectively, in
the HS. Treatment ofFCS either with charcoal or with an ion exchange
resin was demonstrated to remove >99% of the iodothyronines.
Experiments were performed with cells at the near confluent stage
of growth and 48 h after the last medium change. Cells were harvested
by scraping with a rubber policeman, washed twice with ice-cold buffer
(0.25 M sucrose, 0.02 M Tris-HCI, pH 7.6, 1 mM MgCl2, 2 mM
CaC12, 0.1 mM dithiothreitol [DTTJ, 5% glycerol), then resuspended
in the same buffer and sonicated using a sonic dismembrator (Artek
Systems Corp., Farmingdale, NY) for 25 s at a setting of 45. The
sonicate was centrifuged at 800 g for 10 min and the supernatant was
used immediately for determination of I5`D activity as previously
described (8, 9). T3 production rates were quantified by radioimmu-
noassay (RIA) using stable thyroxine (T4) as a substrate at concentrations
of 0.002-3.0 MM in the presence of added DTT. The T4 content of
the supernatant fraction, before the addition of stable T4 or enrichment
with DTT, was determined by RIA in ethanol extracts (8). Protein
concentration was determined by the method of Lowry et al. (10).
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Several experiments were performed to characterize and define the
optimal conditions for quantifying 15)D activity in GH3 cells: (a)
enzyme activity in supernatants was found to be a linear function of
both protein concentration (up to 11 mg/ml) and incubation time (up
to 45 min) and was dependent on the presence of sulflhydryl reducing
agents (maximum activity at 20 mM DTT). (b) No T3 formation was
noted in supernatants heated to 80'C for 45 min before incubation
with T4 and DTT. (c) Incubation of supernatants with known concen-
trations of stable T3 (at 370C for 45 min in the presence of 20 mM
DTT) failed to disclose any evidence of T3 degradation. (d) Enzyme
activity determined 1-4 d after a medium change varied by <15% and
was the same during either the log or near confluent stages of growth.
The uptake of rT3 by GH3 cells was determined by incubating cells
in medium containing a known specific activity of '25I-rT3 (New
England Nuclear, Boston, MA). Cells were then harvested, washed,
and sonicated as above, and the amount of radioactivity in the
supernate fraction was determined. The rT3 content was calculated
after correcting for the proportion of counts due to "25I as determined
by electrophoresis (11). Stable rT3 was obtained from Calbiochem-
Behring Corp., La Jolla, CA.
Kinetic data were analyzed using Eadie-Hofstee plots, and nonlinear
plots were resolved into two components as previously described (9).
Statistical comparison was performed using the unpaired t test. All
results are given as mean±SE.
Results
151D activity in GH3 cell supernatants demonstrated nonlinear
reaction kinetics suggesting the presence of two enzymatic
processes having Km values of 2.4±1.0 nM (n = 4 experiments)
and 0.9±0.3 /iM (Fig. 1). Corresponding values for the maxi-
mum velocity were 23±7 fmol T3/min mg protein and 32±6
fmol T3/min mg protein. The addition of 0.5 mM 6-n-propyl-
2-thiouracil to cell sonicates (in the presence of 5 mM DTT)
inhibited T3 production by <10% at low substrate concentra-
tions (10 nM T4) but by 53% (P < 0.001) at T4 concentrations
of 3 ,M (data not shown). In subsequent experiments 15'D
activity was determined using supernatant substrate concentra-
tions of 10 or 50 nM T4 and 20 mM DTT; these conditions
permit quantification of primarily the low Km process.
The effect on 15'D activity of culturing cells in medium
supplemented with different serum preparations is shown in
Fig. 2. Cells grown in Ham's F-lO medium supplemented with
10% FCS manifested only 46% of the activity noted in cells
cultured in standard medium. However, cells maintained in
serum-free medium or in the presence of 10% resin-treated or
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Figure 1. Kinetic analysis, utilizing an Eadie-Hofstee plot, of 151)
activity in GH3 cells. Cells were cultured in standard medium con-
taining 2.5% FCS and 15% HS. Enzyme activity was determined
using T4 concentrations of 0.002-1.0 MM and 20 mM DTT. T4
concentrations on the abscissa are expressed in nanomoles per liter.
Points represent the mean of duplicate values, which differed <15%.
Prot, protein.
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FCS - Free
Figure 2. The effect of different medium conditions on 151) activity
in GH3 cells. Cells were grown to near confluence in standard me-
dium (FCS/HS) and then transferred and maintained for four addi-
tional days in the medium indicated. 15D activity was determined
using a T4 concentration of 10 nM and 20 mM DTT. Values
represent the mean±SE of triplicate determinations. ., P < 0.001
compared with cells maintained in untreated FCS. Prot, protein.
charcoal-treated FCS showed a two- to 3.5-fold increase in
I5'D activity, suggesting that one or more components of
serum exerted inhibitory effects on enzyme activity. The
addition of T4, T3, or rT3 to the culture medium resulted in
significant inhibitory effects on 15'D activity. Dose response
curves, as determined in serum-free medium, are shown in
Fig. 3. In this experiment, rT3 was somewhat more active than
T4 and 50 times more active than T3 in inhibiting 151D activity.
Additional experiments (n = 5) using both serum-free conditions
and medium supplemented with resin-treated FCS confirmed
that the order of potency of these analogues was rT3 . T4
> T3. In medium supplemented with resin-treated FCS, T3
concentrations of >lO-' M were required to inhibit 151D
activity. Thyronine, at concentrations up to 10-7 M, inhibited
this process by <10%.
The potential of rT3 acting as a competitive substrate with
T4 in the reaction mixture was assessed by determining the
rate of T3 formation in the presence of both added T4 (50
nM) and rTi3. Concentrations of rT3 of up to 1O nM had no
effect on T3 production rates. Quantitation of rT3 cellular
uptake revealed that 4 h after the addition of 10-8 M rT3 to
the culture medium, supernatant concentrations of rT3 were
-5 nM in cells grown in serum-free medium and 0.4 nM in
cells maintained in medium supplemented with resin-treated
FCS. Thus, even at high medium rT3 concentrations, the
supernatant concentrations of rT3 were insufficient to affect
T3 production rates when 50 nM T4 was provided as substrate
in the reaction mixture. Furthermore, the concentration of T4
(as determined by RIA) in supernatants derived from cells
grown in medium supplemented with resin-treated FCS and
either 10-8 M or 10-' M T4 were 0.7 nM and 7 nM, respectively;
concentrations that would not add significantly to the rates of
T3 formation in the reaction mixture.2
2. Based on the measured sonicate protein concentration and the
known values of protein content and cellular volume ofGH cells (12),
the actual intracellular concentrations of rT3 and T4 can be calculated.
For cells incubated for 4 h in medium containing 10% FCS, intracellular
rT3 and T4 concentrations were equal to the total medium concentrations
of these iodothyronines. Under serum-free medium conditions, the
intracellular concentrations were -30-fold greater than the medium
concentrations.
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Figure 3. Dose response curves of the inhibitory effects of thyroid
hormones on 15D) activity in GH3 cells. Cells were grown to near
confluence in standard medium and then transferred and maintained
for four additional days in serum-free Ham's F-10 medium. Iodothy-
ronines were added to the culture medium 4 h before harvesting.
151D activity was determined using a T4 concentration of 50 nM and
20 mM DTT. Points represent the mean of triplicate determinations,
which differed <5%.
The regulatory effect of rT3 on 15D activity was shown to
be quite rapid (Fig. 4). Significant inhibition was noted within
15 min of adding rT3 to the medium and was near maximal
at 2 h. A similar time course of inhibition was shown for T4.
Discussion
I5'D activity in GH3 cells was shown in the present studies to
be a thiol-dependent process with nonlinear reaction kinetics
suggesting the presence of two enzymatic pathways having
markedly different Km values for T4. A differential sensitivity
of these two processes to the inhibitory effects of PTU was
also noted, These findings are similar to those previously
described in homogenates of rat anterior pituitary glands (9,
13) and cerebral cortex (14). Our findings differ, however,
from a prior report using GH3 cells where only a high Km
process (3.8 MM) was identified (15). The failure to detect a
low Km process in this latter study may have been secondary
to the low concentrations of DTT used (2 mM) and the
relative insensitivity of the T3 RIA (3.75 pg/tube lower limits
of detection vs. 0.2 pg/tube in the present studies [8, 91).
Recent studies have shown that low Km 151D activity is
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Figure 4. Time course of the inhibitory effect of 10-8 M rT3 on 151D
activity in GH3 cells. Cells were grown to near confluence in stan-
dard medium and then transferred and maintained in medium con-
taining 10% resin-treated IFCS. The rT3 was added to the culture
medium before harvesting at the times indicated. 151D activity was
determined using a T4 concentration of 50 nM and 20 mM DTT.
Points represent the mean of triplicate determinations, which differed
<5%.
responsible for the vast majority of "local" T3 formation in
the pituitary and depends on thyroid hormone status (8, 13).
In hypothyroid animals, the activity of this process is markedly
elevated, whereas thyroid hormone administration induces a
rapid decrease in T4 to T3 conversion. Our finding that low
Km I5D activity in GH3 cells rapidly responds to medium
thyroid hormone concentrations supports the use of this cell
line as a model system.
The effects of thyroid hormones on I5D activity in various
tissues are complex (16). In liver and kidney homogenates,
rT3 inhibits T3 formation by substrate competition with T4 for
a high Km (type I) I5D process (17). The suppressive effects of
thyroid hormones on low Km (type II) 151) activity in GH3
cells, however, cannot be attributed to this mechanism. Our
demonstration that rT3 is a potent inhibitor of this process
contrasts sharply with the weak agonist activity ofthis analogue
on other metabolic processes (2, 5) and strongly suggests that
a unique regulatory mechanism, independent of the nuclear
T3 receptor, is responsible for this effect. Further evidence for
this is the finding that relatively high concentrations of T3
(10-9 M in medium containing serum), which have been
shown by other investigators to stimulate significantly growth
hormone production and maximally suppress thyrotropin-
releasing hormone receptors in GH3 cells (18), had no effect
on 15D activity. A recent report (19) demonstrating that the
injection of T4 or rT3 in the rat is more effective than T3 in
inhibiting pituitary and cerebral cortex I5D activity, suggests
that the order of iodothyronine potency found in GH3 cells is
also applicable in vivo. The cellular processes responsible for
these regulatory effects are uncertain. Leonard et al. (20),
however, have recently suggested that the T3-dependent inhi-
bition of 15D activity in rat pituitary and cerebral cortex is
mediated by a posttranscriptional mechanism that increases
the rate of degradation or inactivation of the enzyme.
To date, a 5-deiodinase process has not been described in
pituitary tissue and none could be demonstrated in the present
study in GH3 cells when T3 was used as a substrate. This
finding, together with the near equal potency of T4 with rT3,
suggests that the regulatory effects of T4 on 15D activity are
direct and not mediated by conversion to rT3.
An intriguing question raised by these studies is the possible
role of rT3 in the control of T4 to T3 conversion in the
pituitary and brain. Although rT3 appears to be a potent
regulator of this metabolic process, its free concentration in
normal human serum is '40-fold lower than that of T4 (21).
Thus, T4 rather than rT3 is likely to exert the principle
physiologic control over this process. This thesis is consistent
with reports that the administration of rT3 to normal human
subjects has no effect on the serum levels of T4, T3, thyrotropin,
or the thyrotropin response to thyrotropin-releasing hormone
(22, 23). In nonthyroidal illness, however, marked alterations
occur in thyroid hormone metabolism, which may result in
decreased serum free T4 levels and increases in serum free rT3
levels of up to 15-fold (21). Under such circumstances, inhib-
itory effects of rT3 on 151D activity may become significant.
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